Investor and analyst call to discuss RSV vaccines data

GSK held an investor and analyst call hosted by Hal Barron, Chief Scientific Officer and President R&D, Roger Connor, President, GSK Vaccines, and Emmanuel Hanon, SVP and Head of Vaccines R&D, and discussed data on two respiratory syncytial virus (RSV) vaccine candidates to be presented at ID Week.

This event took place on Thursday 22 October at 3:30pm CET / 2:30pm BST / 9:30am EDT.